IRWD

Ironwood Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↑ 8/10
  • Value↑ 5/10
Ironwood Pharmaceuticals sales and earnings growth
IRWD Growth
Good
  • Revenue Y/Y↑ 13.80%
  • EPS Y/Y↑ 420.00%
  • FCF Y/Y↑ 43.10%
Ironwood Pharmaceuticals gross and profit margin trends
IRWD Profitability
Great
  • Gross margin ↑ 100.00%
  • EPS margin↑ 28.30%
  • ROIC 5Y↑ -24.16%
Ironwood Pharmaceuticals net debt vs free cash flow
IRWD Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 3.4
  • Interest coverage↑ 6.1

Ironwood Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks